Humana In-Line on the Top Line

Health insurance provider Humana  reported third-quarter results today before the markets opened, showing that it posted consolidated revenues of $10.32 billion, a 7% increase from the same period in the previous year, and just ahead of the $10.28 billion Capital IQ consensus estimate.

While net income came in at $368 million, or $2.31 per share, down 14% from $426 million, or $2.62 per share, in the same period in 2012, it was $0.14-per-share better than the CapIQ estimates of $2.17 per share.

Humana says its consolidated benefit ratio, which is benefits expense as a percent of premiums, increased because of unfavorable weekday seasonality and unfavorable changes in the seasonal prescription drug utilization pattern due to an influx of low-income beneficiaries who have higher utilization rates.

The health insurance provider expects full-year earnings to be in the range of $8.65 to $8.75 per share on revenues of $40.75 billion to $41.25 billion, mostly in-line with analyst expectations that Humana will post earnings of $8.73 per share on revenues of $$41.31 billion.


The article Humana In-Line on the Top Line originally appeared on

Fool contributor Rich Duprey has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story